APGE
Price
$36.64
Change
-$1.05 (-2.79%)
Updated
May 30 closing price
Capitalization
2.14B
RCUS
Price
$8.93
Change
-$0.58 (-6.10%)
Updated
May 30 closing price
Capitalization
945.55M
61 days until earnings call
Interact to see
Advertisement

APGE vs RCUS

Header iconAPGE vs RCUS Comparison
Open Charts APGE vs RCUSBanner chart's image
Apogee Therapeutics
Price$36.64
Change-$1.05 (-2.79%)
Volume$534.31K
Capitalization2.14B
Arcus Biosciences
Price$8.93
Change-$0.58 (-6.10%)
Volume$1.38M
Capitalization945.55M
APGE vs RCUS Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. RCUS commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (APGE: $36.64 vs. RCUS: $8.93)
Brand notoriety: APGE and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 84% vs. RCUS: 115%
Market capitalization -- APGE: $2.14B vs. RCUS: $945.55M
APGE [@Biotechnology] is valued at $2.14B. RCUS’s [@Biotechnology] market capitalization is $945.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 5 bearish.
  • RCUS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -7.19% price change this week, while RCUS (@Biotechnology) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

APGE is expected to report earnings on May 12, 2025.

RCUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.14B) has a higher market cap than RCUS($946M). APGE YTD gains are higher at: -19.117 vs. RCUS (-40.027). APGE has higher annual earnings (EBITDA): -216.68M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. APGE (521M). APGE has less debt than RCUS: APGE (11.8M) vs RCUS (60M). RCUS has higher revenues than APGE: RCUS (141M) vs APGE (0).
APGERCUSAPGE / RCUS
Capitalization2.14B946M226%
EBITDA-216.68M-377M57%
Gain YTD-19.117-40.02748%
P/E RatioN/AN/A-
Revenue0141M-
Total Cash521M997M52%
Total Debt11.8M60M20%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 18 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRTVX263.59N/A
N/A
Vanguard Russell 2000 Value Index I
NBMRX24.94N/A
N/A
Neuberger Berman M/C Intrinsic Val R6
JIJAX14.35N/A
N/A
JHancock International Dynamic Gr A
PSLCX9.95-0.04
-0.40%
Putnam Small Cap Value C
SCICX42.96-0.21
-0.49%
Columbia Seligman Tech & Info C

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-2.77%
ERAS - APGE
53%
Loosely correlated
-3.45%
SYRE - APGE
53%
Loosely correlated
-1.74%
ELVN - APGE
52%
Loosely correlated
+0.17%
CRNX - APGE
51%
Loosely correlated
-0.03%
KYMR - APGE
51%
Loosely correlated
-2.02%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ACLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-6.10%
ACLX - RCUS
48%
Loosely correlated
-2.54%
XNCR - RCUS
47%
Loosely correlated
+3.43%
APGE - RCUS
47%
Loosely correlated
-2.77%
IMNM - RCUS
46%
Loosely correlated
-2.35%
TRDA - RCUS
45%
Loosely correlated
-3.80%
More